Sky View Investment Advisors, LLC Novartis Ag Transaction History

Sky View Investment Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 18, 2023	BUY	$80.03 - $92.81 $46,017 - $53,365	575 Added 6.64%	9,241 $850,000
Q4 2022 Feb 16, 2023	SELL	$75.55 - $92.52 $33,090 - $40,523	-438 Reduced 4.81%	8,666 $786,000
Q3 2022 Nov 16, 2022	BUY	$74.61 - $87.26 $109,303 - $127,835	1,465 Added 19.18%	9,104 $692,000
Q2 2022 Nov 15, 2022	BUY	$80.52 - $93.75 $615,092 - $716,156	7,639 New	7,639 $646,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Sky View Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sky View Investment Advisors, LLC with notifications on news.